News of the index components BEL-20

Index

BEL20

BE0389555039

Market Closed - Euronext Bruxelles 12:05:02 2024-04-19 pm EDT			5-day change	1st Jan Change
3,828 ^PTS	+0.03%		-0.24%	+3.24%

Apr. 15	Solvay: Deutsche Bank's assessment that the company is well valued causes the share price to fall.	CF
Apr. 04	UCB: new indication in sight for Bimzelx in the USA	CF

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aedifica NV/SA: Repurchase of own shares AED	Apr. 19	GL
Warehouses De Pauw SA Reports Earnings Results for the First Quarter Ended March 31, 2024 WDP	Apr. 19	CI
Umicore: sustainable bonds successfully placed UMI	Apr. 19	CF
Transcript : Warehouses De Pauw SA, Q1 2024 Earnings Call, Apr 19, 2024 WDP	Apr. 19
Umicore Completes Issuance of EUR499 Million Sustainability-linked Notes UMI	Apr. 19	MT
Umicore secures € 499 million in sustainability-linked private debt placement UMI	Apr. 19	AQ
Umicore Secures ?499 Million in Sustainability-Linked Private Debt Placement UMI	Apr. 19	CI
Warehouses De Pauw : Results for Q1 2024 WDP	Apr. 19	PU
Proximus : signs agreement with NRB to acquire additional 5G spectrum PROX	Apr. 18	PU
Belgium’s Solvay Opens Blowing Agent Production Facility in Italy SOLB	Apr. 18	MT
Solvay: inaugurates new production unit in Italy SOLB	Apr. 18	CF
AB INBEV : Bernstein gives a Buy rating ABI	Apr. 18	ZD
Solvay : Annual Integrated Report 2023 SOLB	Apr. 18	PU
D'Ieteren : Repurchase and disposal of own shares DIE	Apr. 17	PU
Solvay releases 2023 annual integrated report SOLB	Apr. 17	GL
AB INBEV : Bernstein maintains a Buy rating ABI	Apr. 17	ZD
Transcript : Proximus PLC - Shareholder/Analyst Call PROX	Apr. 17
Proximus : Art Collection will place a selection of artworks on the market and use the proceeds for new acquisitions PROX	Apr. 17	PU
UCB : FINTEPLA▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) UCB	Apr. 17	PU
Argenx : argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease ARGX	Apr. 16	PU
Syensqo releases inaugural 2023 annual integrated report SYENS	Apr. 16	GL
KBC Group: Update regarding the KBC Group share buyback programme KBC	Apr. 16	GL
Argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease ARGX	Apr. 16	GL
Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy ARGX	Apr. 16	CI
Groupe Bruxelles Lambert : GBL - Transactions sur actions propres 15-04-2024 GBLB	Apr. 15	PU
Groupe Bruxelles Lambert : GBL - Transactions on GBL shares 15-04-2024 GBLB	Apr. 15	PU
Groupe Bruxelles Lambert : GBL - Transacties op GBL-aandelen 15-04-2024 GBLB	Apr. 15	PU
Solvay publishes 2023 quarterly information following restatement and new segmentation reporting SOLB	Apr. 15	GL
Solvay publishes 2023 quarterly information following restatement and new segmentation reporting SOLB	Apr. 15	AQ
UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting UCB	Apr. 15	AQ
Solvay: Deutsche Bank's assessment that the company is well valued causes the share price to fall. SOLB	Apr. 15	CF
Ageas: BNP Paribas buys out Fosun's stake AGS	Apr. 15	CF
Ageas acknowledges BNP Paribas as shareholder AGS	Apr. 14	AQ
Ageas acknowledges BNP Paribas as shareholder AGS	Apr. 14	GL
UCB : Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY▼ (romosozumab) can help to close the treatment gap in osteoporosi UCB	Apr. 12	PU
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV AGS	Apr. 12	GL
Sofina : Liquidity agreement – 12/04/2024 SOF	Apr. 12	PU
Ageas publishes its 2023 reports AGS	Apr. 12	GL
Proximus : NXT and Airbus Public Safety and Security join forces PROX	Apr. 12	PU
Melexis N : 2023 - Melexis Annual Report MELE	Apr. 12	PU